Acacia director gets stock grant for Q2 fees
Sundar Ajay reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sundar Ajay reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP insider Ajay Sundar reported receiving a grant of 4,175 shares of Common Stock at $4.79 per share as Q2 2026 director fees paid in stock instead of cash. Following this award, he directly holds 107,605 shares. As of June 23, 2026, he ceased to be a director of the company.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.001 | 4,175 | $4.79 | $20K |
Footnotes (2)
- F1. As of June 23, 2026, the Reporting Person ceased to be a director of the Issuer.
- F2. Grant of shares of Common Stock in lieu of cash for Q2 2026 director fees.
Key Figures
Key Terms
Grant, award, or other acquisition financial
Common Stock financial
director fees financial
non-derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ajay Sundar report in this Form 4 for ACTG?
Was the ACTG Form 4 transaction a market purchase or sale?
Did Ajay Sundar remain a director of Acacia Research (ACTG) after this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.